Low-grade myofibroblastic sarcoma with abdominal pain, a stuffy nose, hearing loss, and multiple cavity effusion: a case report and literature review

Case report: Low-grade myofibroblastic sarcoma resembling lymphoma on 18F-FDG PET/CT

Low-grade myofibroblastic sarcoma is a rare malignant tumor that arises from mesenchymal tissue and affects the head (particularly the tongue and oral cavity) and neck. It is characterized by local recurrence, with metastases being uncommon. We present a 72-year-old man who initially complained of a painless and progressive mass in the right inguinal region and came for consultation, and a malignant tumor was suspected based on the clinical and pelvic MRI manifestations. The ¹⁸F-FDG PET/CT revealed that the multiple lesions were located in the mediastinum, retroperitoneum, pelvis, and inguinal lymph nodes; hence, lymphoma was considered to be a combination of the symptoms. However, the histology of the ultrasound-guided puncture indicated low-grade myofibroblastic sarcoma. The patient was next administered chemotherapy, but the lesions did not undergo remission.

Low-Grade Malignant Myofibroblastic Sarcoma of the Larynx: A Case Report and Literature Review

Squamous cell carcinomas predominate in laryngeal malignancies, while spindle cell tumors, typically derived from non-epithelial tissues, are uncommon, accounting for 0.3%-1% of all malignant laryngeal tumors. Low-grade malignant myofibroblastic sarcoma (LGMS) is an extremely rare, atypical myofibroblastic tumor classified as a spindle cell tumor that primarily affects the head and neck region. There have been few reports in the literature regarding the LGMS of the larynx. LGMS of the larynx was discovered during a pathological biopsy. There was no recurrence during the 6-month follow-up after the total laryngectomy.

Primary low-grade myofibroblastic sarcoma: A rare case report of this tumor in the orbit and literature review

Low-grade myofibroblastic sarcoma (LGMS) is an exceedingly rare, malignant tumor with myofibroblastic differentiation. It frequently occurs in the oral cavity and extremities, despite being classified as a distinct entity by the World Health Organization (WHO). Here, we report a rare case of orbital LGMS occurring in an 11-month-old baby with a 3.2 × 2.4 × 2.1 cm mass. LGMS was diagnosed based on the histological and immunohistochemical findings. Previous literature suggests that surgical resection with clear margins is an appropriate method for the treatment of LGMS, and combined adjuvant therapy (local radiotherapy with or without chemotherapy) can improve the prognosis, but further studies are needed.